These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 11300474

  • 1. Human T-cell responses to HLA-A-restricted high binding affinity peptides of human papillomavirus type 18 proteins E6 and E7.
    Rudolf MP, Man S, Melief CJ, Sette A, Kast WM.
    Clin Cancer Res; 2001 Mar; 7(3 Suppl):788s-795s. PubMed ID: 11300474
    [Abstract] [Full Text] [Related]

  • 2. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.
    Ressing ME, Sette A, Brandt RM, Ruppert J, Wentworth PA, Hartman M, Oseroff C, Grey HM, Melief CJ, Kast WM.
    J Immunol; 1995 Jun 01; 154(11):5934-43. PubMed ID: 7538538
    [Abstract] [Full Text] [Related]

  • 3. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins.
    Kast WM, Brandt RM, Sidney J, Drijfhout JW, Kubo RT, Grey HM, Melief CJ, Sette A.
    J Immunol; 1994 Apr 15; 152(8):3904-12. PubMed ID: 7511661
    [Abstract] [Full Text] [Related]

  • 4. Disease-stage variance in functional CD4(+) T-cell responses against novel pan-human leukocyte antigen-D region presented human papillomavirus-16 E7 epitopes.
    Warrino DE, Olson WC, Knapp WT, Scarrow MI, D'Ambrosio-Brennan LJ, Guido RS, Edwards RP, Kast WM, Storkus WJ.
    Clin Cancer Res; 2004 May 15; 10(10):3301-8. PubMed ID: 15161683
    [Abstract] [Full Text] [Related]

  • 5. Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells.
    Santin AD, Hermonat PL, Ravaggi A, Bellone S, Roman JJ, Jayaprabhu S, Pecorelli S, Parham GP, Cannon MJ.
    Clin Cancer Res; 2001 Mar 15; 7(3 Suppl):804s-810s. PubMed ID: 11300476
    [Abstract] [Full Text] [Related]

  • 6. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
    Welters MJ, Kenter GG, Piersma SJ, Vloon AP, Löwik MJ, Berends-van der Meer DM, Drijfhout JW, Valentijn AR, Wafelman AR, Oostendorp J, Fleuren GJ, Offringa R, Melief CJ, van der Burg SH.
    Clin Cancer Res; 2008 Jan 01; 14(1):178-87. PubMed ID: 18172269
    [Abstract] [Full Text] [Related]

  • 7. Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity.
    Kenter GG, Welters MJ, Valentijn AR, Lowik MJ, Berends-van der Meer DM, Vloon AP, Drijfhout JW, Wafelman AR, Oostendorp J, Fleuren GJ, Offringa R, van der Burg SH, Melief CJ.
    Clin Cancer Res; 2008 Jan 01; 14(1):169-77. PubMed ID: 18172268
    [Abstract] [Full Text] [Related]

  • 8. Synthetic peptides induce a cytotoxic response against human papillomavirus type-18.
    Castellanos MR, Hayes RL, Maiman MA.
    Gynecol Oncol; 2001 Jul 01; 82(1):77-83. PubMed ID: 11426965
    [Abstract] [Full Text] [Related]

  • 9. Mapping of cytotoxic T lymphocytes epitopes in E7 antigen of human papillomavirus type 11.
    Xu Y, Zhu KJ, Chen XZ, Zhao KJ, Lu ZM, Cheng H.
    Arch Dermatol Res; 2008 Jun 01; 300(5):235-42. PubMed ID: 18299861
    [Abstract] [Full Text] [Related]

  • 10. Identification of a naturally processed HLA A0201-restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein.
    Bartholomew JS, Stacey SN, Coles B, Burt DJ, Arrand JR, Stern PL.
    Eur J Immunol; 1994 Dec 01; 24(12):3175-9. PubMed ID: 7805746
    [Abstract] [Full Text] [Related]

  • 11. Cervical carcinoma cells transfected with the CD80 gene elicit a primary cytotoxic T lymphocyte response specific for HPV 16 E7 antigens.
    Kaufmann AM, Gissmann L, Schreckenberger C, Qiao L.
    Cancer Gene Ther; 1997 Dec 01; 4(6):377-82. PubMed ID: 9408608
    [Abstract] [Full Text] [Related]

  • 12. Induction of specific CD8+ T-lymphocyte responses using a human papillomavirus-16 E6/E7 fusion protein and autologous dendritic cells.
    Murakami M, Gurski KJ, Marincola FM, Ackland J, Steller MA.
    Cancer Res; 1999 Mar 15; 59(6):1184-7. PubMed ID: 10096544
    [Abstract] [Full Text] [Related]

  • 13. Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens.
    Youde SJ, Dunbar PR, Evans EM, Fiander AN, Borysiewicz LK, Cerundolo V, Man S.
    Cancer Res; 2000 Jan 15; 60(2):365-71. PubMed ID: 10667589
    [Abstract] [Full Text] [Related]

  • 14. Identification of human papillomavirus 16-E6 protein-derived peptides with the potential to generate cytotoxic T-lymphocytes toward human leukocyte antigen-A24+ cervical cancer.
    Hara M, Matsueda S, Tamura M, Takedatsu H, Tanaka M, Kawano K, Mochizuki K, Kamura T, Itoh K, Harada M.
    Int J Oncol; 2005 Nov 15; 27(5):1371-9. PubMed ID: 16211234
    [Abstract] [Full Text] [Related]

  • 15. Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia.
    Baldwin PJ, van der Burg SH, Boswell CM, Offringa R, Hickling JK, Dobson J, Roberts JS, Latimer JA, Moseley RP, Coleman N, Stanley MA, Sterling JC.
    Clin Cancer Res; 2003 Nov 01; 9(14):5205-13. PubMed ID: 14614000
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Class I MHC-peptide interactions: structural requirements and functional implications.
    Grey HM, Ruppert J, Vitiello A, Sidney J, Kast WM, Kubo RT, Sette A.
    Cancer Surv; 1995 Nov 01; 22():37-49. PubMed ID: 7536628
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7.
    Steller MA, Gurski KJ, Murakami M, Daniel RW, Shah KV, Celis E, Sette A, Trimble EL, Park RC, Marincola FM.
    Clin Cancer Res; 1998 Sep 01; 4(9):2103-9. PubMed ID: 9748126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.